[시장보고서]심장병 및 신경계 IVD 시장 규모, 점유율, 동향 분석 보고서, 제품 유형별, 최종 용도별, 기술별, 지역별 전망 및 예측(2023-2030년)

심장병 및 신경계 IVD 시장 규모, 점유율, 동향 분석 보고서, 제품 유형별, 최종 용도별, 기술별, 지역별 전망 및 예측(2023-2030년)

Global IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Regional Outlook and Forecast, 2023 - 2030

상품코드 : 1461704 해당 상품은 즉시 배송 가능합니다

리서치사 : KBV Research

발행일 : 2024년 03월

페이지 정보 : 영문 241 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,600

￦ 5,341,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320

￦ 6,409,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048

￦ 8,973,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

세계 심장학 및 신경학 분야의 IVD 시장 규모는 예측 기간 동안 9.3%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 299억 달러에 달할 것으로 예상됩니다.

또한, 세계 인구의 고령화와 함께 심혈관 질환 및 신경 장애와 같은 노화 관련 건강 상태의 유병률이 증가하고 있으며, 2021년 4월 미국심장학회가 발표한 보고서에 따르면 심혈관 질환은 아시아에서 사망 원인 1위이며, 1990년부터 2019년까지 아시아의 심혈관 관련 사망자 수는 560만 명에서 1,080만 명으로 증가했다고 합니다. 또한 Eurostat에 따르면 2020년 EU에서 정신 및 행동 장애로 인한 사망자는 19만 4,000명으로 전체 사망자의 3.7%를 나타낼 것으로 예상했습니다.

그러나 심장병학 및 신경학 분야의 체외 진단 시험의 규제 경로에는 종종 복잡하고 장기간에 걸친 승인 절차가 수반됩니다. 규제 기준을 충족하는 데 필요한 비용과 자원으로 인해 연구개발에 대한 관심과 자금이 분산되어 진화하는 진단 수요에 대응할 수 있는 최첨단 기술을 채택하지 못할 수 있습니다. 까다로운 규제 환경은 특정 진입자, 특히 복잡한 승인 절차를 통과할 수 있는 자금력이 없는 진입자 시장 접근을 제한할 수 있습니다.

또한, 코로나19 사태로 인해 일상적인 의료 서비스가 중단되면서 심장병학 및 신경학 분야의 체외 진단 테스트 도입에 영향을 미치고 있습니다. 봉쇄 및 사회적 거리두기로 인한 제한으로 인해 원격 의료 및 원격 환자 모니터링의 도입이 가속화되었습니다. 심장학 분야에서는 대면 진료를 최소화하면서 지속적인 환자 치료를 보장하기 위해 재택 체외진단 테스트의 사용이 크게 증가했습니다. 따라서 코로나19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다.

북미
- 북미 심장병 및 신경계 IVD 시장 : 국가별
  - 미국
  - 캐나다
  - 멕시코
  - 기타 북미
유럽
- 유럽 심장병 및 신경계 IVD 시장 : 국가별
  - 독일
  - 영국
  - 프랑스
  - 러시아
  - 스페인
  - 이탈리아
  - 기타 유럽
아시아태평양
- 아시아태평양 심장병 및 신경계 IVD 시장 : 국가별
  - 중국
  - 일본
  - 인도
  - 한국
  - 싱가포르
  - 말레이시아
  - 기타 아시아태평양
라틴아메리카/중동 및 아프리카
- 라틴아메리카/중동 및 아프리카 심장병 및 신경계 IVD 시장 : 국가별
  - 브라질
  - 아르헨티나
  - 아랍에미리트(UAE)
  - 사우디아라비아
  - 남아프리카공화국
  - 나이지리아
  - 기타 라틴아메리카/중동 및 아프리카

제8장 기업 개요

Thermo Fisher Scientific, Inc
F Hoffmann-La Roche Ltd.
Sysmex Corporation
Siemens Healthineers AG(Siemens AG)
Quest Diagnostics Incorporated
Abbott Laboratories
Bio-Rad laboratories, Inc
Danaher Corporation(Beckman Coulter)
Becton, Dickinson, and Company
Natera Inc

제9장 심장병 및 신경계 IVD 시장의 성공 필수 조건

LSH

영문 목차

영문목차

The Global IVD In Cardiology And Neurology Market size is expected to reach $29.9 billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

North America is often at the forefront of technological advancements in healthcare. Consequently, the North America segment captured $6,288.5 million revenue in the market in 2022. In North America, the high incidence of chronic diseases (e.g., neurological disorders and cardiovascular conditions) increases the demand for diagnostic solutions. IVD tests are crucial in early detection, monitoring, and personalized treatment strategies. Thus, the segment will grow rapidly in the upcoming years.

The primary objective of public health campaigns and educational initiatives is to enhance public consciousness regarding the dangers and manifestations of neurological disorders and cardiovascular diseases (CVDs). Increased access to health information empowers individuals to be more proactive about their health. Informed patients are more likely to request diagnostic tests and screenings based on their understanding of risk elements and the importance of early detection.

Additionally, as the global population ages, there is a higher prevalence of age-related health conditions, including cardiovascular diseases and neurological disorders. According to a report published by the American College of Cardiology in April 2021, cardiovascular disease is Asia's leading cause of mortality. From 1990 to 2019, the number of cardiovascular-related fatalities in Asia increased from 5.6 million to 10.8 million. Moreover, as per Eurostat, in 2020, there were 194,000 deaths in the EU resulting from mental and behavioral disorders, equivalent to 3.7 % of all deaths.

However, the regulatory pathway for IVD tests in cardiology and neurology often involves intricate and prolonged approval processes. The costs and resources required to meet regulatory standards may divert attention and funds away from research and development efforts, hindering the introduction of cutting-edge technologies to address evolving diagnostic needs. The stringent regulatory environment can result in limited market access for certain players, especially those lacking the financial means to navigate the complex approval processes.

Moreover, the onset of the pandemic led to disruptions in routine healthcare services, affecting the adoption of IVD tests in cardiology and neurology. The limitations imposed by lockdowns and social distancing measures accelerated the adoption of telemedicine and remote patient monitoring. In cardiology, there was a notable increase in the use of home-based IVD tests to ensure continued patient care while minimizing in-person visits. Therefore, the COVID-19 pandemic positively impacted the market.

By Product Type Analysis

Based on product type, the market is segmented into instruments, reagents & consumables, and software & services. In 2022, the reagents and consumables segment garnered the 42.34% revenue share in the market. As the demand for diagnostic testing in cardiology and neurology rises, the need for reagents and consumables used in these tests tends to grow proportionately.

By End Use Analysis

Based on end-use, the market is divided into hospitals, clinical laboratories, and others. In 2022, the clinical laboratories segment witnessed a 26.70% revenue share in the market. The growing incidence of neurological and cardiovascular disorders has prompted a surge in need for diagnostic examinations.

By Technology Analysis

On the basis of technology, the market is divided into immunoassays, molecular diagnostics, hematology, and others. In 2022, the immunoassays segment witnessed the 38.08% revenue share in the market. Cardiology uses immunoassays to measure cardiac biomarkers such as troponins, creatine kinase-MB (CK-MB), and brain natriuretic peptide (BNP).

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 28.81% revenue share in the market. Cardiology IVD tests in Europe often focus on cardiac biomarkers, lipid profiles, and genetic testing for hereditary cardiovascular conditions.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Sysmex Corporation
Siemens Healthineers AG (Siemens AG)
Quest Diagnostics Incorporated
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
Becton, Dickinson and Company
Natera, Inc.

Global IVD In Cardiology And Neurology Market Report Segmentation

By Product Type

Reagents & Consumables
Instruments
Software & Services

By End Use

Hospitals
Clinical Laboratories
Others

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global IVD In Cardiology And Neurology Market, by Product Type
- 1.4.2Global IVD In Cardiology And Neurology Market, by End Use
- 1.4.3Global IVD In Cardiology And Neurology Market, by Technology
- 1.4.4Global IVD In Cardiology And Neurology Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Global IVD In Cardiology And Neurology Market by Product Type

4.1Global Reagents & Consumables Market by Region
4.2Global Instruments Market by Region
4.3Global Software & Services Market by Region

Chapter 5.Global IVD In Cardiology And Neurology Market by End-use

5.1Global Hospitals Market by Region
5.2Global Clinical Laboratories Market by Region
5.3Global Others Market by Region

Chapter 6.Global IVD In Cardiology And Neurology Market by Technology

6.1Global Immunoassays Market by Region
6.2Global Molecular Diagnostics Market by Region
6.3Global Hematology Market by Region
6.4Global Others Market by Region

Chapter 7.Global IVD In Cardiology And Neurology Market by Region

7.1North America IVD In Cardiology And Neurology Market
- 7.1.1North America IVD In Cardiology And Neurology Market by Product Type
  - 7.1.1.1North America Reagents & Consumables Market by Country
  - 7.1.1.2North America Instruments Market by Country
  - 7.1.1.3North America Software & Services Market by Country
- 7.1.2North America IVD In Cardiology And Neurology Market by End-use
  - 7.1.2.1North America Hospitals Market by Country
  - 7.1.2.2North America Clinical Laboratories Market by Country
  - 7.1.2.3North America Others Market by Country
- 7.1.3North America IVD In Cardiology And Neurology Market by Technology
  - 7.1.3.1North America Immunoassays Market by Country
  - 7.1.3.2North America Molecular Diagnostics Market by Country
  - 7.1.3.3North America Hematology Market by Country
  - 7.1.3.4North America Others Market by Country
- 7.1.4North America IVD In Cardiology And Neurology Market by Country
  - 7.1.4.1US IVD In Cardiology And Neurology Market
    - 7.1.4.1.1US IVD In Cardiology And Neurology Market by Product Type
    - 7.1.4.1.2US IVD In Cardiology And Neurology Market by End-use
    - 7.1.4.1.3US IVD In Cardiology And Neurology Market by Technology
  - 7.1.4.2Canada IVD In Cardiology And Neurology Market
    - 7.1.4.2.1Canada IVD In Cardiology And Neurology Market by Product Type
    - 7.1.4.2.2Canada IVD In Cardiology And Neurology Market by End-use
    - 7.1.4.2.3Canada IVD In Cardiology And Neurology Market by Technology
  - 7.1.4.3Mexico IVD In Cardiology And Neurology Market
    - 7.1.4.3.1Mexico IVD In Cardiology And Neurology Market by Product Type
    - 7.1.4.3.2Mexico IVD In Cardiology And Neurology Market by End-use
    - 7.1.4.3.3Mexico IVD In Cardiology And Neurology Market by Technology
  - 7.1.4.4Rest of North America IVD In Cardiology And Neurology Market
    - 7.1.4.4.1Rest of North America IVD In Cardiology And Neurology Market by Product Type
    - 7.1.4.4.2Rest of North America IVD In Cardiology And Neurology Market by End-use
    - 7.1.4.4.3Rest of North America IVD In Cardiology And Neurology Market by Technology
7.2Europe IVD In Cardiology And Neurology Market
- 7.2.1Europe IVD In Cardiology And Neurology Market by Product Type
  - 7.2.1.1Europe Reagents & Consumables Market by Country
  - 7.2.1.2Europe Instruments Market by Country
  - 7.2.1.3Europe Software & Services Market by Country
- 7.2.2Europe IVD In Cardiology And Neurology Market by End-use
  - 7.2.2.1Europe Hospitals Market by Country
  - 7.2.2.2Europe Clinical Laboratories Market by Country
  - 7.2.2.3Europe Others Market by Country
- 7.2.3Europe IVD In Cardiology And Neurology Market by Technology
  - 7.2.3.1Europe Immunoassays Market by Country
  - 7.2.3.2Europe Molecular Diagnostics Market by Country
  - 7.2.3.3Europe Hematology Market by Country
  - 7.2.3.4Europe Others Market by Country
- 7.2.4Europe IVD In Cardiology And Neurology Market by Country
  - 7.2.4.1Germany IVD In Cardiology And Neurology Market
    - 7.2.4.1.1Germany IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.1.2Germany IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.1.3Germany IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.2UK IVD In Cardiology And Neurology Market
    - 7.2.4.2.1UK IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.2.2UK IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.2.3UK IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.3France IVD In Cardiology And Neurology Market
    - 7.2.4.3.1France IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.3.2France IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.3.3France IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.4Russia IVD In Cardiology And Neurology Market
    - 7.2.4.4.1Russia IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.4.2Russia IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.4.3Russia IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.5Spain IVD In Cardiology And Neurology Market
    - 7.2.4.5.1Spain IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.5.2Spain IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.5.3Spain IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.6Italy IVD In Cardiology And Neurology Market
    - 7.2.4.6.1Italy IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.6.2Italy IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.6.3Italy IVD In Cardiology And Neurology Market by Technology
  - 7.2.4.7Rest of Europe IVD In Cardiology And Neurology Market
    - 7.2.4.7.1Rest of Europe IVD In Cardiology And Neurology Market by Product Type
    - 7.2.4.7.2Rest of Europe IVD In Cardiology And Neurology Market by End-use
    - 7.2.4.7.3Rest of Europe IVD In Cardiology And Neurology Market by Technology
7.3Asia Pacific IVD In Cardiology And Neurology Market
- 7.3.1Asia Pacific IVD In Cardiology And Neurology Market by Product Type
  - 7.3.1.1Asia Pacific Reagents & Consumables Market by Country
  - 7.3.1.2Asia Pacific Instruments Market by Country
  - 7.3.1.3Asia Pacific Software & Services Market by Country
- 7.3.2Asia Pacific IVD In Cardiology And Neurology Market by End-use
  - 7.3.2.1Asia Pacific Hospitals Market by Country
  - 7.3.2.2Asia Pacific Clinical Laboratories Market by Country
  - 7.3.2.3Asia Pacific Others Market by Country
- 7.3.3Asia Pacific IVD In Cardiology And Neurology Market by Technology
  - 7.3.3.1Asia Pacific Immunoassays Market by Country
  - 7.3.3.2Asia Pacific Molecular Diagnostics Market by Country
  - 7.3.3.3Asia Pacific Hematology Market by Country
  - 7.3.3.4Asia Pacific Others Market by Country
- 7.3.4Asia Pacific IVD In Cardiology And Neurology Market by Country
  - 7.3.4.1China IVD In Cardiology And Neurology Market
    - 7.3.4.1.1China IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.1.2China IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.1.3China IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.2Japan IVD In Cardiology And Neurology Market
    - 7.3.4.2.1Japan IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.2.2Japan IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.2.3Japan IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.3India IVD In Cardiology And Neurology Market
    - 7.3.4.3.1India IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.3.2India IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.3.3India IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.4South Korea IVD In Cardiology And Neurology Market
    - 7.3.4.4.1South Korea IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.4.2South Korea IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.4.3South Korea IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.5Singapore IVD In Cardiology And Neurology Market
    - 7.3.4.5.1Singapore IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.5.2Singapore IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.5.3Singapore IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.6Malaysia IVD In Cardiology And Neurology Market
    - 7.3.4.6.1Malaysia IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.6.2Malaysia IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.6.3Malaysia IVD In Cardiology And Neurology Market by Technology
  - 7.3.4.7Rest of Asia Pacific IVD In Cardiology And Neurology Market
    - 7.3.4.7.1Rest of Asia Pacific IVD In Cardiology And Neurology Market by Product Type
    - 7.3.4.7.2Rest of Asia Pacific IVD In Cardiology And Neurology Market by End-use
    - 7.3.4.7.3Rest of Asia Pacific IVD In Cardiology And Neurology Market by Technology
7.4LAMEA IVD In Cardiology And Neurology Market
- 7.4.1LAMEA IVD In Cardiology And Neurology Market by Product Type
  - 7.4.1.1LAMEA Reagents & Consumables Market by Country
  - 7.4.1.2LAMEA Instruments Market by Country
  - 7.4.1.3LAMEA Software & Services Market by Country
- 7.4.2LAMEA IVD In Cardiology And Neurology Market by End-use
  - 7.4.2.1LAMEA Hospitals Market by Country
  - 7.4.2.2LAMEA Clinical Laboratories Market by Country
  - 7.4.2.3LAMEA Others Market by Country
- 7.4.3LAMEA IVD In Cardiology And Neurology Market by Technology
  - 7.4.3.1LAMEA Immunoassays Market by Country
  - 7.4.3.2LAMEA Molecular Diagnostics Market by Country
  - 7.4.3.3LAMEA Hematology Market by Country
  - 7.4.3.4LAMEA Others Market by Country
- 7.4.4LAMEA IVD In Cardiology And Neurology Market by Country
  - 7.4.4.1Brazil IVD In Cardiology And Neurology Market
    - 7.4.4.1.1Brazil IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.1.2Brazil IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.1.3Brazil IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.2Argentina IVD In Cardiology And Neurology Market
    - 7.4.4.2.1Argentina IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.2.2Argentina IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.2.3Argentina IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.3UAE IVD In Cardiology And Neurology Market
    - 7.4.4.3.1UAE IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.3.2UAE IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.3.3UAE IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.4Saudi Arabia IVD In Cardiology And Neurology Market
    - 7.4.4.4.1Saudi Arabia IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.4.2Saudi Arabia IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.4.3Saudi Arabia IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.5South Africa IVD In Cardiology And Neurology Market
    - 7.4.4.5.1South Africa IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.5.2South Africa IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.5.3South Africa IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.6Nigeria IVD In Cardiology And Neurology Market
    - 7.4.4.6.1Nigeria IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.6.2Nigeria IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.6.3Nigeria IVD In Cardiology And Neurology Market by Technology
  - 7.4.4.7Rest of LAMEA IVD In Cardiology And Neurology Market
    - 7.4.4.7.1Rest of LAMEA IVD In Cardiology And Neurology Market by Product Type
    - 7.4.4.7.2Rest of LAMEA IVD In Cardiology And Neurology Market by End-use
    - 7.4.4.7.3Rest of LAMEA IVD In Cardiology And Neurology Market by Technology

Chapter 8.Company Profiles

8.1Thermo Fisher Scientific, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expenses
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Partnerships, Collaborations, and Agreements:
- 8.1.6SWOT Analysis
8.2F. Hoffmann-La Roche Ltd.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
8.3Sysmex Corporation
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5SWOT Analysis
8.4Siemens Healthineers AG (Siemens AG)
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Partnerships, Collaborations, and Agreements:
- 8.4.6SWOT Analysis
8.5Quest Diagnostics Incorporated
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental Analysis
- 8.5.4Recent strategies and developments:
  - 8.5.4.1Acquisition and Mergers:
- 8.5.5SWOT Analysis
8.6Abbott Laboratories
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Partnerships, Collaborations, and Agreements:
  - 8.6.5.2Acquisition and Mergers:
- 8.6.6SWOT Analysis
8.7Bio-Rad laboratories, Inc.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5SWOT Analysis
8.8Danaher Corporation (Beckman Coulter)
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9Becton, Dickinson, and Company
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expense
- 8.9.5SWOT Analysis
8.10.Natera Inc.
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

한글목차

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 세계의 심장병 및 신경계 IVD 시장 : 제품 유형별

제5장 세계의 심장병 및 신경계 IVD 시장 : 최종 용도별

제6장 세계의 심장병 및 신경계 IVD 시장 : 기술별

제7장 세계의 심장병 및 신경계 IVD 시장 : 지역별